CIDRAP newsletters options
As infections outside of China increase, China's total tops 75,000 cases.
"The day may come when we may need to implement such measures as seen in Asia," a CDC official says.
The antibiotics were tied to a 55% increased risk of malformation.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
York University this week announced a $2 million grant from the Canadian Institutes of Health Research to support the development of a global network to address infectious disease and antimicrobial resistance.
After a month-long rise, US flu levels dropped last week, the Centers for Disease Control and Prevention (CDC) said today in its weekly FluView report. But most regions are still experiencing elevated influenza activity, and 13 more pediatric deaths were recorded, raising the 2019-20 flu season total to 105.
"We're starting to understand the amount of resistance that will selected for by mass antibiotics."
Also, South Korea cases almost double, to 104, many part of a church cluster.
In the US, the vaccine did not protect against H1N1, which is now circulating more.
The United Kingdom's Food Standards Agency (FSA) released two surveillance reports this week on antimicrobial resistance (AMR) in chicken meat.
The findings question the "more is better" mantra for preventing MRSA.
Data suggest the possibility that COVID-19 could be transmitted via respiratory, fecal-oral, or body fluid routes.
Also today, 79 more Diamond Princess infections were reported—raising cruise ship totals to 621— and the WHO details stepped-up response measures regarding the Westerdam ship in Cambodia.
Qatar's Ministry of Public Health (MOPH) yesterday confirmed a new MERS-CoV case in a 65-year-old man, the fourth case recorded in Qatar since December.
Research news includes evidence of person-to-person spread before symptoms.
HHS is partnering with Sanofi and Johnson & Johnson to develop vaccines and therapeutics.
The World Health Organization's (WHO's) online Ebola dashboard shows a case count of 3,433 today, with a single newly confirmed case. The death toll is now 2,249 in an outbreak that has lasted 18 months in northeastern Democratic Republic of the Congo (DRC).
CARB-X said today it has awarded Lytica Therapeutics, of Cambridge, Massachusetts, up to $5.3 million to develop antibacterial peptides that have broad activity against multidrug-resistant bacteria for treating lung and other infections.
A study of 44,672 cases reveals that 14% were severe and 5% critical.
A major reduction in the use of fluoroquinolones has driven a 12% decrease in total antibiotic use in Canadian hospitals in recent years, according to a new study in Antimicrobial Resistance and Infection Control.
